HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann Holstein Selected Research

vanutide cridificar

1/2017Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
1/2016Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann Holstein Research Topics

Disease

2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2016
1Asthma (Bronchial Asthma)
01/2021
1Inflammation (Inflammations)
01/2021
1Edema (Dropsy)
01/2016

Drug/Important Bio-Agent (IBA)

2vanutide cridificarIBA
01/2017 - 01/2016
2Amyloid (Amyloid Fibrils)IBA
01/2017 - 01/2016
2VaccinesIBA
01/2017 - 01/2016
2saponin QA-21V1 (QS21)IBA
01/2017 - 01/2016
1Particulate MatterIBA
01/2021
1IronIBA
01/2021

Therapy/Procedure

1Therapeutics
01/2016